Hepalink (9989) Schedules Board Meeting on October 30, 2025 to Review Third Quarterly Results

Bulletin Express

10/17

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (Stock code: 9989) has announced that its board of directors will convene on October 30, 2025. The meeting will focus on reviewing and approving the company’s third quarterly results for the nine-month period ended September 30, 2025, as well as finalizing plans for their publication.

The announcement is dated October 17, 2025. According to the information disclosed, the executive directors of the company include Li Li, Li Tan, Shan Yu, and Zhang Ping, while the independent non-executive directors are Lu Chuan, Huang Peng, and Yi Ming.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1179453281"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1179453281\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1179453281?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-17 16:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179453281","market":"hk","top_or_hot":-1,"title":"Hepalink (9989) Schedules Board Meeting on October 30, 2025 to Review Third Quarterly Results","media":"Bulletin Express","content":"<p>Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (Stock code: 9989) has announced that its board of directors will convene on October 30, 2025. The meeting will focus on reviewing and approving the company’s third quarterly results for the nine-month period ended September 30, 2025, as well as finalizing plans for their publication.</p>\n<p>The announcement is dated October 17, 2025. According to the information disclosed, the executive directors of the company include Li Li, Li Tan, Shan Yu, and Zhang Ping, while the independent non-executive directors are Lu Chuan, Huang Peng, and Yi Ming.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hepalink (9989) Schedules Board Meeting on October 30, 2025 to Review Third Quarterly Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHepalink (9989) Schedules Board Meeting on October 30, 2025 to Review Third Quarterly Results\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2025-10-17 16:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (Stock code: 9989) has announced that its board of directors will convene on October 30, 2025. The meeting will focus on reviewing and approving the company’s third quarterly results for the nine-month period ended September 30, 2025, as well as finalizing plans for their publication.</p>\n<p>The announcement is dated October 17, 2025. According to the information disclosed, the executive directors of the company include Li Li, Li Tan, Shan Yu, and Zhang Ping, while the independent non-executive directors are Lu Chuan, Huang Peng, and Yi Ming.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09989","symbol_name":"海普瑞","start_time":0,"source_url":"","article_id":"1179453281","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179453281","pubTimestamp":1760690438,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (Stock code: 9989) has announced that its board of directors will convene on October 30, 2025. The meeting will focus on reviewing and approving the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09989":"海普瑞"},"translate_title":"海普瑞(9989)定于2025年10月30日召开董事会审议第三季度业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09989":1},"content_text":"Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (Stock code: 9989) has announced that its board of directors will convene on October 30, 2025. The meeting will focus on reviewing and approving the company’s third quarterly results for the nine-month period ended September 30, 2025, as well as finalizing plans for their publication.\nThe announcement is dated October 17, 2025. According to the information disclosed, the executive directors of the company include Li Li, Li Tan, Shan Yu, and Zhang Ping, while the independent non-executive directors are Lu Chuan, Huang Peng, and Yi Ming.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}